2,3,4,5-tetrahydroxypentanal has been researched along with Cardiovascular Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibarrola, J | 1 |
| Matilla, L | 1 |
| Martínez-Martínez, E | 1 |
| Gueret, A | 1 |
| Fernández-Celis, A | 1 |
| Henry, JP | 1 |
| Nicol, L | 1 |
| Jaisser, F | 1 |
| Mulder, P | 1 |
| Ouvrard-Pascaud, A | 1 |
| López-Andrés, N | 1 |
1 other study available for 2,3,4,5-tetrahydroxypentanal and Cardiovascular Stroke
| Article | Year |
|---|---|
Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
Topics: Animals; Biomarkers; Blood Proteins; Disease Models, Animal; Galectin 3; Galectins; Gene Expression; | 2019 |